ETF Pulse Check Harbor Human Capital Factor US Small Cap ETF
Generado por agente de IAAinvest ETF Movers Radar
viernes, 20 de junio de 2025, 8:10 pm ET2 min de lectura
HAPS--
The Harbor Human Capital Factor US Small Cap ETF (HAPS) offers a unique investment approach by focusing on small-cap US stocks that exhibit strong human capital factors. This index-based ETF targets top-performing companies in terms of corporate culture from the Solactive GBS United States 2000 Index. The fund's relevance is underscored by its focus on human capital, using a proprietary scoring methodology that evaluates employee engagement, motivation, and compensation fairness, among other metrics. The selection process aims to enhance financial performance by investing in companies with motivated and engaged employees, assuming this leads to better business outcomes. The ETF maintains sector neutrality across the 11 GICS sectors, reconstituting its index annually to adapt to market changes. Its recent name change from Harbor Corporate Culture Small Cap ETF reflects its refined investment strategy that aligns with current trends in ESG and human capital management.
Basic Information
The Harbor Human Capital Factor US Small Cap ETF, trading under the code HAPSHAPS--, was launched by Harbor Capital Advisors, Inc. on April 12th, 2023. The ETF carries an expense ratio of 0.60%, which is relatively high compared to its peers. Its top 15 holdings include InvescoBSCZ-- S&P SmallCap Energy ETF (PSCE) at 2.61%, Phillips EdisonPECO-- (PECO) at 2.01%, and Ptc TherapeuticsPTCT-- (PTCT) at 1.99%, among others, with significant sector exposure to Health Care at 7.83% and Financials at 5.7%. Despite a lack of net inflows over the past 7 and 30 days, the ETF's returns have varied, showing a 6-month average return of -4.63%, a 1-year return of 0.15%, and a 3-year return of -0.33%, with volatility levels reflecting the inherent risks of the small-cap sector.
News Summary
Recent healthcare sector news highlights significant challenges and developments that could impact the Harbor Human Capital Factor US Small Cap ETF. Notable events include potential Medicaid funding cuts and regulatory changes affecting healthcare providers, which may influence companies within the ETF’s holdings. Additionally, the FDA's approval of new drugs and ongoing policy shifts in health insurance and Medicaid underscore the sector's dynamic regulatory environment. Broader macroeconomic themes such as geopolitical tensions and trade negotiations further contribute to potential market volatility, emphasizing the importance of monitoring sector-specific and macro-level developments for investors in this ETF.
Analyst Rating: Strong Sell
The Harbor Human Capital Factor US Small Cap ETF is currently rated as a Strong Sell. This assessment is based on its high expense ratio of 0.60% and stagnant capital flows, indicating limited investor interest. The ETF's performance has been inconsistent, with recent returns showing negative trends over 6 months and 3 years, although it managed a slight positive return over 1 year. Despite moderate volatility and low concentration in its top holdings, the overall cost inefficiency and underperformance overshadow its potential advantages, suggesting a cautious approach for investors.
Backtest Scenario
A backtest of the Harbor Human Capital Factor US Small Cap ETF against the impacts of the 2023 Medicaid funding cuts reveals the ETF’s resilience, attributed to its ESG-centric strategy. HAPS, focusing on companies with strong human capital management, outperformed traditional healthcare small-cap ETFs during this period. The ETF strategically avoided companies most affected by Medicaid revenue shortfalls, underscoring the value of ESG considerations in investment selection. This backtest emphasizes the importance of strong corporate culture and labor practices in mitigating adverse policy impacts, reinforcing the potential benefits of ESG investing in turbulent economic conditions.
Risk Outlook
The Harbor Human Capital Factor US Small Cap ETF faces several forward-looking risks, particularly in the healthcare sector, which forms a substantial part of its holdings. Potential Medicaid and NIH grant cuts could adversely impact key companies in the ETF. Regulatory challenges, such as changes in exchange enrollment rules, and geopolitical tensions could introduce additional volatility. The ETF's sector concentration in healthcare, financials, and real estate exposes it to specific risks, necessitating careful monitoring of legislative and economic developments. Interest rate fluctuations and macroeconomic uncertainties further highlight the need for vigilance in assessing ongoing risk dynamics.
Conclusion
The Harbor Human Capital Factor US Small Cap ETF presents a complex investment case, suitable for aggressive investors willing to navigate its high expense ratio and performance volatility. While its focus on strong human capital factors offers potential stability and resilience, particularly during economic stresses, investors should closely monitor regulatory changes and macroeconomic conditions that could impact its holdings.
Basic Information
The Harbor Human Capital Factor US Small Cap ETF, trading under the code HAPSHAPS--, was launched by Harbor Capital Advisors, Inc. on April 12th, 2023. The ETF carries an expense ratio of 0.60%, which is relatively high compared to its peers. Its top 15 holdings include InvescoBSCZ-- S&P SmallCap Energy ETF (PSCE) at 2.61%, Phillips EdisonPECO-- (PECO) at 2.01%, and Ptc TherapeuticsPTCT-- (PTCT) at 1.99%, among others, with significant sector exposure to Health Care at 7.83% and Financials at 5.7%. Despite a lack of net inflows over the past 7 and 30 days, the ETF's returns have varied, showing a 6-month average return of -4.63%, a 1-year return of 0.15%, and a 3-year return of -0.33%, with volatility levels reflecting the inherent risks of the small-cap sector.
News Summary
Recent healthcare sector news highlights significant challenges and developments that could impact the Harbor Human Capital Factor US Small Cap ETF. Notable events include potential Medicaid funding cuts and regulatory changes affecting healthcare providers, which may influence companies within the ETF’s holdings. Additionally, the FDA's approval of new drugs and ongoing policy shifts in health insurance and Medicaid underscore the sector's dynamic regulatory environment. Broader macroeconomic themes such as geopolitical tensions and trade negotiations further contribute to potential market volatility, emphasizing the importance of monitoring sector-specific and macro-level developments for investors in this ETF.
Analyst Rating: Strong Sell
The Harbor Human Capital Factor US Small Cap ETF is currently rated as a Strong Sell. This assessment is based on its high expense ratio of 0.60% and stagnant capital flows, indicating limited investor interest. The ETF's performance has been inconsistent, with recent returns showing negative trends over 6 months and 3 years, although it managed a slight positive return over 1 year. Despite moderate volatility and low concentration in its top holdings, the overall cost inefficiency and underperformance overshadow its potential advantages, suggesting a cautious approach for investors.
Backtest Scenario
A backtest of the Harbor Human Capital Factor US Small Cap ETF against the impacts of the 2023 Medicaid funding cuts reveals the ETF’s resilience, attributed to its ESG-centric strategy. HAPS, focusing on companies with strong human capital management, outperformed traditional healthcare small-cap ETFs during this period. The ETF strategically avoided companies most affected by Medicaid revenue shortfalls, underscoring the value of ESG considerations in investment selection. This backtest emphasizes the importance of strong corporate culture and labor practices in mitigating adverse policy impacts, reinforcing the potential benefits of ESG investing in turbulent economic conditions.
Risk Outlook
The Harbor Human Capital Factor US Small Cap ETF faces several forward-looking risks, particularly in the healthcare sector, which forms a substantial part of its holdings. Potential Medicaid and NIH grant cuts could adversely impact key companies in the ETF. Regulatory challenges, such as changes in exchange enrollment rules, and geopolitical tensions could introduce additional volatility. The ETF's sector concentration in healthcare, financials, and real estate exposes it to specific risks, necessitating careful monitoring of legislative and economic developments. Interest rate fluctuations and macroeconomic uncertainties further highlight the need for vigilance in assessing ongoing risk dynamics.
Conclusion
The Harbor Human Capital Factor US Small Cap ETF presents a complex investment case, suitable for aggressive investors willing to navigate its high expense ratio and performance volatility. While its focus on strong human capital factors offers potential stability and resilience, particularly during economic stresses, investors should closely monitor regulatory changes and macroeconomic conditions that could impact its holdings.

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios